| Overview
Collaborations
Partnering
People
History
Facility
|  Research Collaborations and Licensing
Agreements
Contact
Dr. Thomas Borcholte, Chief Business Officer
Tel.: +49 (0)89 - 41 31 38 - 0
E-Mail: licensing@wilex.com
Major Active Collaborations, Strategic Alliances and Licensing
Agreements
WILEX collaborates and has license agreements with a number
of leading academic and clinical institutions as well as pharmaceutical
companies in Europe and North
America. The company considers these relationships to be important
to its ability to gain access to and exploit possible new developments
within its business
focus.
|
| Collaborating Partner |
Area of collaborations |
Read more |
|
| Bayer Corporation, Tarrytown, NY (USA) |
Licensing agreement on MN/CA
IX antigen of the RENCAREX®* antibody |
Press Release |
 |
| Centocor Inc., Malvern PA (USA)/University
of Leiden (Netherlands) |
Licensing of G250/RENCAREX® antibody |
Press releases |
 |
| Ludwig Institute for Cancer Research,
New York City, NY (USA) |
Clinical Phase I and II
trials with G250 antibody and 124Iodine-G250 in the US |
Press
release |
 |
| Fox Chase Cancer Center, Philadelphia,
PA (USA) |
Collaboration to conduct
clinical Phase I and II trials with WX-UK1 in combination with capecitabine.
The studies are supported with a USD 5.0 million grant from the U.S. Department
of Defense Breast Cancer Research Program |
Press
release |
 |
| Department of Urology of the David Geffen
School of Medicine at UCLA, University of California, Los Angeles, CA (USA) |
Collaboration with a research
group of Prof. Arie Belldegrun to examine the pre-clinical efficacy of
the G250 (RENCAREX®) antibody in mouse models |
|
 |
Slovak Academy of Science, Bratislava,
(Slovakia)
|
Collaboration with a research
group of Prof. Pastorek to examine the CAIX antigen and the mode of action
of the G250 (RENCAREX®) antibody in different models |
|
|
| Erasmus Medical Center, Rotterdam, (Netherlands) |
Research collaboration on
pre-clinical tests of WILEX’s drug candidates. |
|
 |
| |
| Licence agreements are an
important part of the Company’s commercialisation strategy.
You will find details of existing partnerships or options for further cooperations
here. |
| * temporary name while under development |
|
|
| |
|
|
| © 2006 WILEX AG |
|
|
|
| |
|
|
|
